0 avis
Biological evaluation of 153Sm and 166Ho complexes with tetraazamacrocycles containing methylcarboxylate and/or methylphosphonate pendant arms
Archive ouverte
Edité par CCSD ; Oldenbourg Wissenschaftsverlag -
International audience. 153Sm and 166Ho complexes with two series of tetraazamacrocyclic ligands containing methylcarboxylate and/or methylphosphonate pendant arms were synthesized and their charge, lipophilicity, protein binding and in vitro and in vivo behaviour evaluated. The first series has the same backbone, a 14-membered tetraazamacrocycle containing a pyridine unit with different pendant arms, namely methylcarboxylates (ac3py14) or methylphosphonates (MeP2py14 and P3py14). The second series comprises 12- to 14-membered tetraazamacrocycles having methylcarboxylates and/or methylphosphonates as pendant arms (trans-DO2A2P, TRITA, TRITP, TETA and TETP). The 153Sm/166Ho complexes with the 14-membered tetraazamacrocycles containing the pyridine unit are neutral, hydrophilic, have a significant plasmatic protein binding, are unstable in vivo and present a slow rate of radioactivity excretion and high hepatic retention. 153Sm/166Ho complexes with the 12- to 14-membered tetraazamacrocycles are quantitatively prepared, except those with TETP. These complexes are hydrophilic, have an over-all negative charge and present a medium to low plasmatic protein binding. The 153Sm/ 166Ho-trans-M-DO2A2P, 153Sm/166Ho-TRITA and 166Ho-TRITP complexes are stable in vitro and in vivo, presenting a rapid clearance from main organs and a high rate of whole body radioactivity excretion. Biological profile of 153Sm/166Ho-TRITA complexes makes them promising candidates for therapy when conjugated to a biomolecule, while 166Ho-TRITP is potentially useful for bone targeting due to its considerable uptake by bone.
Consulter en ligne
Suggestions
Du même auteur
